In low grade NHL, serum markers can in addition aid in the decision on when to initiate therapy. New-comers in the serum marker business are the cytokines, some of which can now be detected in serum. 展开 关键词: Tumour markers malignant lymphomas Hodgkins's disease thymidine kinase ...
Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Ann Hematol 2005;84: 588–93 - SY, JT, et al. () Citation Context ...s. Using a cut-off threshold of 2.0 for the FLC ratio, 100% PPV and 96.8% NPV was noted, enabling us to differentiate...
We have reported the expression of MUC1 in multiple myeloma (MM) cells and the estab... E Borek - 《Tumor Biology》 被引量: 14发表: 1984年 Serum cytokeratin 19 fragment 21‐1 is a useful tumor marker for the assessment of extramammary Paget's disease Cytokeratin 19 fragment 21-1 (...
Disclosed are a cancer marker-detecting composition comprising an agent for measuring an mRNA or protein expression level of eIF3m, a cancer diagnosis kit ... YS Lee,SH Goh,SH Hong,... 被引量: 0发表: 2012年 THE ASSOCIATION OF RADIOLOGY AND PAAF FOR DIAGNOSING MYELOMAS Extramedullary plasmo...
These findings suggest that loss of SETD7 is an early prognostic marker for metastasis in breast cancer. SETD7 also exhibits tumor-suppressive effects in lung and bladder cancer. In lung cancer, SETD7 suppresses migration and invasion by downregulating the JAK2/STAT3 pathway105. In bladder ...
The position of albumin as a molecular weight marker was confirmed using silver staining. LMM Low molecular mass. HMM High molecular mass. Original blots are presented in Supplementary Figure S14. Full size image We performed DNA deaminase activity assays with each fraction with or without RNase ...
This invention can, fusing with the epithelium organizational piece of prostate swelling symptom organization or the immunity cell of the mammal which immunity is done and the myeloma cell of the mammal in the epithelium cell, reacts vis-a-vis the prostate secretory cell, but the monoclonal antib...
Multiple myeloma mTORC1: mTOR complex 1 mTORC2: mTOR complex 2 NDRG2: N-Myc downstream regulated gene 2 NEAA: Nonessential amino acid PC: Plasma cell PD-1: Programmed cell death protein 1 PDK1: Pyruvate dehydrogenase kinase 1 PRPP: Phosphoribosylpyrophosphate PSAT1: Phosphoserine ...
No preclinical study of CAR-T cells for BC has targeted the serum tumor marker carcinoembryonic antigen (CEA), while a clinical trial of CAR-T cell therapy targeting CEA to remedy BC subjects is underway (NCT04348643) (Fig.3). In conclusion, although many institutions have registered many BC...
myeloma, and imatinib-treated gastrointestinal stromal cancer, in spite of slight differences in tissue-specificity or drug-precise pharmacological action.131,158,159,160,161,162However, since there are also considerable shortcomings associated with the induction of ICD for cancer therapy, the ...